TNFα blockade mediates bone protection in antigen-induced arthritis by reducing osteoclast precursor supply.
Bone. 2018 Feb; 107:56-65 Uster S, Matos Coelho F, Aeberli D, Stein JV, Hofstetter W, Engelhardt R, Seitz M.
Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Calcif Tissue Int 2018 2018 Feb;102(2):227-250. doi: 10.1007/s00223-017-0353-5. Epub 2017 Oct 27. Sousa S, Clézardin P
Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2018 Feb;29(2):265-286. doi: 10.1007/s00198-017-4339-y. Epub 2018 Jan 6. Varahra A, Rodrigues IB, MacDermid JC, Bryant D, Birmingham T.
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
Blood Cells Mol Dis. 2018 Feb;68:173-179. doi:10.1016/j.bcmd.2016.10.017 Giraldo P, Andrade-Campos M, Alfonso P, Irun P, Atutxa K, Acedo A, Barez A, Blanes M, Diaz-Morant V, Fernández-Galán MA, Franco R, Gil-Cortes C, Giner V, Ibañez A, … Leer más
Osteoporosis in chronic liver disease
Liver Int. 2018 Feb 26. doi: 10.1111/liv.13730 Guañabens N, Parés A
Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis.
Menopause. 2018 Feb 16. doi: 10.1097/GME.0000000000001080. [Epub ahead of print]. McClung MR, Harvey NC, Fitzpatrick LA, Miller PD, Hattersley G, Wang Y, Cosman F. https://www.ncbi.nlm.nih.gov/pubmed/29462094
The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.
J Bone Miner Res. 2018 Feb 22. doi: 10.1002/jbmr.3381. [Epub ahead of print] Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, Harvey NC, Holland R, Howe A, McCloskey E, O’Neill TW, … Leer más
Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial.
Neurosurgery. 2018 Mar 14. doi: 10.1093/neuros/nyy017. [Epub ahead of print] Beall DP, Chambers MR, Thomas S, Amburgy J, Webb JR Jr, Goodman BS, Datta DK, Easton RW, Linville D 2nd, Talati S, Tillman JB
Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates.
Calcif Tissue Int. 2018 Feb 14. doi: 10.1007/s00223-018-0404-6. [Epub ahead of print] Horne AM, Mihov B, Reid IR.
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D. Osteoporos Int. 2018 Feb;29(2):323-328. doi: 10.1007/s00198-017-4304-9. Epub 2017 Nov 22.
